Treatment used in U.S. too expensive for those in Ireland
Aug 15, 2011
A new diagnostic test can help individuals who suffer from breast cancer find out if they need chemotherapy after surgery or if they do not. This can help fight the disease while ensuring that a person does not have to endure certain treatments. This test is already readily used in the U.S., but in Ireland it is considered to expensive for individuals who suffer from the disease to afford it.
The test allows doctors to accurately predict if the disease will come back within 10 years, so they can tell if chemotherapy is needed. This helps in both instances where they didn't think it was needed but it was and vice versa.
The United States uses the treatment, and Britain is currently in testing to ensure that it works before providing it to the public.
According to the American Cancer Society, one in eight women in the U.S. will eventually be diagnosed with breast cancer at some point during their lifetime. It is the second leading cause of the cancer death among women, second only to lung cancer.